Compare Okta, Inc. (OKTA) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Okta, Inc. vs Revolution Medicines Inc. Common Stock — how do they compare? Okta, Inc. trades at $232.13 (market cap $38.50B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Okta, Inc. and Revolution Medicines Inc. Common Stock are close in size by market cap, and Okta, Inc. is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Okta, Inc. for 44 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| OKTA | RVMD | |
|---|---|---|
Market Cap | $38.50B | $40.32B |
Volume | 2,479,621 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $220.21 | $221.15 |
52-Week Low | $62.93 | $47.50 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $36.25B | $37.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKTA trades at $220.21, up 1.01% on the day, with a bullish technical signal from moving averages and strong analyst support (73.58% buy ratings). The company reported a net income of $28 million in 2025, marking a return to profitability after losses in prior years, with revenue growing to $2.61 billion. Recent news highlights its AI agent security initiatives, including the Blueprint Alliance unveiled at Oktane 2026.
The outlook is positive due to earnings beats, AI-driven growth potential, and improving cash flow, but risks include high valuation multiples (P/E of 132.66) and competitive pressures in cybersecurity. The stock trades above the consensus price target of $201.30, suggesting near-term consolidation may occur despite long-term growth prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
